Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Discovery

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2159-8290.CD-14-1129PMID 25929848PMCID PMC4643059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers

  2017cited by this paper
• Oncotator: Cancer Variant Annotation Tool

  2015cited by this paper
• Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

  2015cited by this paper
• Detecting Copy Number Changes and Structural Rearrangements Using DNA Sequencing

  2014cited by this paper
• Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398.

  2014cited by this paper
• A phase 1b open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers: Preliminary antitumor activity and pharmacodynamic data.

  2014cited by this paper
• Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

  2014cited by this paper
• Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

  2014cited by this paper
• Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

  2014cited by this paper
• FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

  2014cited by this paper
• Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH

  2014cited by this paper
• Serpins promote cancer cell survival and vascular co-option in brain metastasis.

  2014cited by this paper
• PyClone: statistical inference of clonal population structure in cancer

  2014cited by this paper
• Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

  2013cited by this paper
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

  2013cited by this paper
• Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer

  2013cited by this paper
• Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

  2013cited by this paper
• Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

  2013cited by this paper
• Prognostic Value of Fibroblast Growth Factor Receptor 1 Gene Locus Amplification in Resected Lung Squamous Cell Carcinoma

  2013cited by this paper
• Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

  2013cited by this paper
• Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models

  2012cited by this paper
• Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy.

  2012cited by this paper
• High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.

  2012cited by this paper
• Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

  2012cited by this paper
• Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

  2011cited by this paper
• Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases

  2011cited by this paper
• Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

  2011cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

  2010cited by this paper
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

  2010cited by this paper
• WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

  2009cited by this paper
• Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

  2007cited by this paper
• Differential expression of individual gamma-protocadherins during mouse brain development.

  2005cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

  2002cited by this paper
• Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

  1998cited by this paper
• Metastatic pattern in adenocarcinoma of the lung. An autopsy study from a cohort of 137 consecutive patients with complete resection.

  1995cited by this paper
• Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.

  1984cited by this paper

• Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells

  2026cites this paper
• Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics

  2025cites this paper
• Molecular and clonal evolution of primary lesions vs. brain metastasis in EGFR-mutated NSCLC: a retrospective cohort study

  2025cites this paper
• Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases

  2025cites this paper
• Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)

  2025cites this paper
• Rethinking metastatic brain cancer as a CNS disease.

  2025cites this paper
• Squamous Non-Small Cell Lung Cancer: Current and Emerging Treatment Options.

  2025cites this paper
• Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer

  2024cites this paper
• Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150

  2024cites this paper
• Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy

  2024cites this paper
• Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases

  2024cites this paper
• Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives

  2024cites this paper
• Alterations in Astrocyte Subpopulations in Glioma and Identification of Cuproptosis-Related Genes Using Single-Cell RNA Sequencing

  2024cites this paper
• Molecular evolution of central nervous system metastasis and therapeutic implications.

  2024cites this paper
• Lung Cancer with Brain Metastasis—Treatment Strategies and Molecular Characteristics

  2024cites this paper
• Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer

  2023cites this paper
• Advances in the Molecular Landscape of Lung Cancer Brain Metastasis

  2023cites this paper
• Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches

  2023cites this paper
• Identifying New Contributors to Brain Metastasis in Lung Adenocarcinoma: A Transcriptomic Meta-Analysis

  2023cites this paper
• Metastatic Lesions of the Brain and Spine.

  2023cites this paper
• Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.

  2023cites this paper
• Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs

  2023cites this paper
• Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”

  2023cites this paper
• CAR T-cells to treat brain tumors.

  2023cites this paper
• Trials, tribunals, and opportunities for lung cancer KRASG12C brain metastases.

  2022cites this paper
• Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung.

  2022cites this paper
• Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC

  2022cites this paper
• New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells

  2022cites this paper
• Targeting NFE2L2/KEAP1 mutations in advanced non-small cell lung cancer with the TORC1/2 inhibitor TAK-228.

  2022cites this paper
• Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment.

  2022cites this paper
• Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer

  2022cites this paper
• Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies

  2022cites this paper
• Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases

  2022cites this paper
• Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity.

  2022cites this paper
• Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer

  2021cites this paper
• Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy

  2021cites this paper
• Recent advances in preclinical models for lung squamous cell carcinoma

  2021cites this paper
• Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies.

  2021cites this paper
• The Infratentorial Localization of Brain Metastases May Correlate with Specific Clinical Characteristics and Portend Worse Outcomes Based on Voxel-Wise Mapping

  2021cites this paper
• Advances in Lung Cancer Driver Genes Associated With Brain Metastasis

  2021cites this paper
• Glial and myeloid heterogeneity in the brain tumour microenvironment

  2021cites this paper
• Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier

  2021cites this paper
• Mitochondrial sirtuins genetic variations and gastric cancer risk: evidence from retrospective observational study.

  2021cites this paper
• A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC Patients (NCI 10327): Rationale and Study Design

  2021cites this paper
• Molecular Profiles of Brain Metastases: A Focus on Heterogeneity

  2021cites this paper
• Clinical value of upfront cranial radiotherapy in osimertinib-treated EGFR-mutant non-small-cell lung cancer with brain metastases.

  2021cites this paper
• Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung

  2021influential citation
• Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

  2020cites this paper
• Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors

  2020cites this paper
• The Role of the ECM in Lung Cancer Dormancy and Outgrowth

  2020cites this paper
• Immunologic and immunogenomic aspects of tumor progression.

  2020cites this paper
• Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors

  2020cites this paper
• A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

  2020cites this paper
• Tumor microenvironment differences between primary tumor and brain metastases

  2020cites this paper
• Next-Generation Sequencing at High Sequencing Depth as a Tool to Study the Evolution of Metastasis Driven by Genetic Change Events of Lung Squamous Cell Carcinoma

  2020cites this paper
• Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.

  2020cites this paper
• 脑脊液ctDNA对非小细胞肺癌脑膜转移患者的临床价值

  2020cites this paper
• Brain metastasis models: What should we aim to achieve better treatments?

  2020cites this paper
• Metastasis-directed therapy for oligometastasis and beyond

  2020cites this paper
• Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity

  2020cites this paper
• Basic Biology of Brain Metastasis

  2020cites this paper
• Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design.

  2020cites this paper
• An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.

  2020cites this paper
• Primary tumor and metastasis—sectioning the different steps of the metastatic cascade

  2020cites this paper
• Specific gut microbiome signature predicts the early-stage lung cancer

  2020cites this paper
• Tyrosine Kinase Inhibitors Could Be Effective Against Non-small Cell Lung Cancer Brain Metastases Harboring Uncommon EGFR Mutations

  2020cites this paper
• Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors

  2020cites this paper
• Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.

  2019cites this paper
• Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases

  2019cites this paper
• From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC

  2019cites this paper
• Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

  2019cites this paper
• A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer

  2019cites this paper
• Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer

  2019cites this paper
• New Treatment Options in Advanced Squamous Cell Lung Cancer.

  2019cites this paper
• Sleeping Beauty Mouse Models of Cancer: Microenvironmental Influences on Cancer Genetics

  2019cites this paper
• Clonality of circulating tumor cells in breast cancer brain metastasis patients

  2019cites this paper
• Radiation Therapy in Non-small-Cell Lung Cancer

  2019cites this paper
• Microenvironmental Heterogeneity in Brain Malignancies

  2019cites this paper
• The characterization of lung microbiome in lung cancer patients with different clinicopathology.

  2019cites this paper
• Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients

  2019cites this paper
• How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases

  2019cites this paper
• Lung cancer

  2019cites this paper
• Non–small‐cell Lung Cancer With Brain Metastasis at Presentation

  2018cites this paper
• Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion

  2018cites this paper
• Targeted sequencing reveals distinct pathogenic variants in Chinese patients with lung adenocarcinoma brain metastases.

  2018cites this paper
• Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis

  2018cites this paper
• Recent advances in managing brain metastasis

  2018cites this paper
• Histologic transformation of non-small-cell lung cancer in brain metastases

  2018cites this paper
• Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma

  2018cites this paper
• Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma.

  2018cites this paper
• Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases

  2018cites this paper
• The Evolving Landscape of Brain Metastasis.

  2018cites this paper
• STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis

  2018cites this paper
• Mechanisms and Therapy for Cancer Metastasis to the Brain

  2018cites this paper
• Genomic Applications in Pulmonary Malignancies

  2018cites this paper
• Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer

  2017cites this paper
• Metronome Chemotherapiekonzepte

  2017influential citation
• Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment‐Naïve Lesions

  2017cites this paper
• Relevance of genetic alterations in squamous and small cell lung cancer.

  2017cites this paper
• PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.

  2017cites this paper